Megan Stanifer

Dr. Megan Stanifer

University Hospital Heidelberg
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSteffen Klein
Steffen Klein
MCMirko Cortese
Mirko Cortese
SWSophie L. Winter
Sophie L. Winter
MWMoritz Wachsmuth-Melm
Moritz Wachsmuth-Melm
CNChristopher Neufeldt
Christopher Neufeldt
PCPetr Chlanda
Petr Chlanda
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID19 pandemic, is a highly pathogenic β-coronavirus. As other coronaviruses, SARS-CoV-2 is enveloped, replicates in the cytoplasm and assembles at intracellular membranes. Here, we structurally characterize the viral replication compartment and report critical insights into the budding mechanism of the virus, and the structure of extracellular virions close to their native state by in situ cryo-electron tomography and subtomogram averaging. We directly visualize RNA filaments inside the double membrane vesicles, compartments associated with viral replication. The RNA filaments show a diameter consistent with double-stranded RNA and frequent branching likely representing RNA secondary structures. We report that assembled S trimers in lumenal cisternae do not alone induce membrane bending but laterally reorganize on the envelope during virion assembly. The viral ribonucleoprotein complexes (vRNPs) are accumulated at the curved membrane characteristic for budding sites suggesting that vRNP recruitment is enhanced by membrane curvature. Subtomogram averaging shows that vRNPs are distinct cylindrical assemblies. We propose that the genome is packaged around multiple separate vRNP complexes, thereby allowing incorporation of the unusually large coronavirus genome into the virion while maintaining high steric flexibility between the vRNPs.

12 August 2020 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
VTViet Loan Dao Thi
Viet Loan Dao Thi
KHKonrad Herbst
Konrad Herbst
KBKathleen Boerner
Kathleen Boerner
MMMatthias Meurer
Matthias Meurer
LKLukas Pm Kremer
Lukas Pm Kremer
SASimon Anders
Simon Anders
A colorimetric isothermal RNA amplification method was shown to detect SARS-CoV-2 RNA in clinical samples with excellent sensitivity and specificity.

19 November 2004 in Science
Verified
Journal Article
Closed access
PDF file
GEGwendolyn F. Elphick
Gwendolyn F. Elphick
WQWilliam Querbes
William Querbes
JJJoslynn A. Jordan
Joslynn A. Jordan
GGGretchen V. Gee
Gretchen V. Gee
SESylvia Eash
Sylvia Eash
WAWalter Atwood
Walter Atwood
The human polyomavirus, JCV, causes the fatal demyelinating disease progressive multifocal leukoencephalopathy in immunocompromised patients. We found that the serotonergic receptor 5HT 2A R could act as the cellular receptor for JCV on human glial cells. The 5HT 2A receptor antagonists inhibited JCV infection, and monoclonal antibodies directed at 5HT 2A receptors blocked infection of glial cells by JCV, but not by SV40. Transfection of 5HT 2A receptor–negative HeLa cells with a 5HT 2A receptor rescued virus infection, and this infection was blocked by antibody to the 5HT 2A receptor. A tagged 5HT 2A receptor colocalized with labeled JCV in an endosomal compartment following internalization. Serotonin receptor antagonists may thus be useful in the treatment of progressive multifocal leukoencephalopathy.

13 July 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JKJana Koch
Jana Koch
Zina Maria UckeleyZina Maria Uckeley
Zina Maria Uckeley
PDPatricio Doldan
Patricio Doldan
MSMegan Stanifer
Megan Stanifer
SBSteeve Boulant
Steeve Boulant
Pierre-Yves LozachPierre-Yves Lozach
Pierre-Yves Lozach
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 December 2020 in Cell Host & Microbe
Verified
Journal Article
Closed access
MCMirko Cortese
Mirko Cortese
JLJi-Young Lee
Ji-Young Lee
BCBerati Cerikan
Berati Cerikan
CNChristopher J. Neufeldt
Christopher J. Neufeldt
VOViola M.J. Oorschot
Viola M.J. Oorschot
RBRalf Bartenschlager
Ralf Bartenschlager

1 July 2020 in Cell Reports
Verified
Journal Article
Open access
MSMegan Stanifer
Megan Stanifer
CKCarmon Kee
Carmon Kee
MCMirko Cortese
Mirko Cortese
CZCamila Metz Zumaran
Camila Metz Zumaran
SSSergio Heli Triana Sierra
Sergio Heli Triana Sierra
SBSteeve Boulant
Steeve Boulant
Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is an unprecedented worldwide health problem that requires concerted and global approaches to stop the coronavirus 2019 (COVID-19) pandemic. Although SARS-CoV-2 primarily targets lung epithelium cells, there is growing evidence that the intestinal epithelium is also infected. Here, using both colon-derived cell lines and primary non-transformed colon organoids, we engage in the first comprehensive analysis of the SARS-CoV-2 life cycle in human intestinal epithelial cells (hIECs). Our results demonstrate that hIECs fully support SARS-CoV-2 infection, replication, and production of infectious de novo virus particles. We found that viral infection elicits an extremely robust intrinsic immune response where interferon-mediated responses are efficient at controlling SARS-CoV-2 replication and de novo virus production. Taken together, our data demonstrate that hIECs are a productive site of SARS-CoV-2 replication and suggest that the enteric phase of SARS-CoV-2 may participate in the pathologies observed in COVID-19 patients by contributing to increasing patient viremia and fueling an exacerbated cytokine response.